
Sign up to save your podcasts
Or


In this episode, Scott Wagers chats with Dr. Mark Tepper, CEO of EuMentis Therapeutics and a season innovator in life science and healthcare. The discussion ranges from the difficulties of developing therapies for autism to making basic scientists more translational. Mark opens up about his personal philosophy of getting through the many challenges of medical research and entrepreneurship. He also shares insights on guiding medical teams on performing in a more productive and collaborative way, leading to creative outputs that could stand the test of time.
By Scott WagersIn this episode, Scott Wagers chats with Dr. Mark Tepper, CEO of EuMentis Therapeutics and a season innovator in life science and healthcare. The discussion ranges from the difficulties of developing therapies for autism to making basic scientists more translational. Mark opens up about his personal philosophy of getting through the many challenges of medical research and entrepreneurship. He also shares insights on guiding medical teams on performing in a more productive and collaborative way, leading to creative outputs that could stand the test of time.